USCWA
OGN icon

U.S. Capital Wealth Advisors’s Organon & Co OGN Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,221
Closed -$120K – 1018
2025
Q3 		$120K Sell
11,221
-7,597
-40% -$74.6K ﹤0.01% 919
2025
Q2 		$182K Sell
18,818
-463
-2% -$4.78K 0.01% 850
2025
Q1 		$287K Buy
19,281
+334
+2% +$5.14K 0.01% 709
2024
Q4 		$283K Buy
18,947
+152
+0.8% +$2.48K 0.01% 704
2024
Q3 		$360K Buy
18,795
+8,220
+78% +$170K 0.01% 545
2024
Q2 		$219K Sell
10,575
-91,472
-90% -$1.82M 0.01% 629
2024
Q1 		$1.92M Sell
102,047
-145,444
-59% -$2.5M 0.07% 243
2023
Q4 		$3.57M Buy
247,491
+74,242
+43% +$1.01M 0.14% 150
2023
Q3 		$3.01M Buy
173,249
+57,583
+50% +$1.2M 0.14% 146
2023
Q2 		$2.41M Buy
+115,666
New +$2.51M 0.11% 181
2023
Q1 		– Sell
-2,164
Closed -$60.4K – 1229
2022
Q4 		$60.4K Buy
+2,164
New +$55.3K ﹤0.01% 838

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

U.S. Capital Wealth Advisors's OGN Position: Q4 2025 in Review

U.S. Capital Wealth Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 11,221 shares — an estimated $120K sold.

U.S. Capital Wealth Advisors first reported a position in OGN in Q4 2022 and held it in 11 quarters. The position peaked at $3.57M in Q4 2023. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • U.S. Capital Wealth Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 11,221 Organon & Co shares in Q4 2025, an estimated $120K.
  • U.S. Capital Wealth Advisors first reported a position in Organon & Co in Q4 2022 and held it in 11 quarters.
  • U.S. Capital Wealth Advisors's Organon & Co position peaked at $3.57M in Q4 2023.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on U.S. Capital Wealth Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.